Portfolio Co Investors 2026 for Advent Life Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Advent Life Sciences accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $2.1B. The median disclosed raise is $62M, and the largest is Nalu Medical at $396M, ahead of Beacon Therapeutics ($290M) and AGTC ($290M).
The names that recur most often on these co-invested cap tables are Advent Life Sciences (18 companies), Forbion (3 companies), OrbiMed (3 companies), Columbus Venture Partners (3 companies), Novo Holdings (2 companies), Syncona (2 companies). By latest disclosed round, the market skews Series B (6), Series A (6), Growth (2), Series D (1).
Companies tracked: 18
Disclosed funding total: $2.1B across 18 companies
Median disclosed raise: $62M
Largest raise: Nalu Medical — $396M
Stage mix: Series B 6 · Series A 6 · Growth 2 · Series D 1
